DOCSLIB.ORG

Download Product List

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Download Product List Promotional Products till stocks last Know more CAS MPN SAP CODE NAME PACK 7440-50-8 039682.22 ALF-039682-22 Copper powder, -100 mesh, 99.999% (metals basis) 100GR 151-21-3 J67606.36 ALF-J67606-36 Sodium n-dodecyl sulfate, 99%, Molecular Biology Grade 500GR 38628-51-2 A15081.22 ALF-A15081-22 3-(4-Carboxyphenyl)propionic acid, 98% 100GR 503-17-3W A13823.22 ALF-A13823-22 2-Butyne, 98% 100GR 7440-06-4 042370.FI ALF-042370-FI Platinum foil, 0.127mm (0.005in) thick, Premion|r, 99.99% (metals basis) 50x50MM 7440-67-7 000418.36 ALF-000418-36 Zirconium powder, -325 mesh, packaged in water 500GR 7440-06-4 012076.06 ALF-012076-06 Platinum black 5GR Tungsten powder, APS 4-6 micron, Puratronic|r, 99.999% (metals basis), 7440-33-7 039691.18 ALF-039691-18 50GR Mo <1ppm 7789-17-5 035729.30 ALF-035729-30 Cesium iodide, ultra dry, 99.998% (metals basis) 250GR 7440-21-3 012681.36 ALF-012681-36 Silicon powder, crystalline,-325 mesh, 99.5% (metals basis) 500GR 203927-98-4 H55817.03 ALF-H55817-03 9,9-Di-n-hexylfluorene-2,7-diboronic acid, 97% 1GR 943-73-7 H27295.14 ALF-H27295-14 L-Homophenylalanine, 98% 25GR 112022-83-0 L14582.AC ALF-L14582-AC (R)-2-Methyl-CBS-oxazaborolidine, 1M soln. in toluene 25ML 775-16-6 A13426.22 ALF-A13426-22 1-Benzyl-3-pyrrolidinone, 98% 100GR 563-67-7 012890.18 ALF-012890-18 Rubidium acetate, 99.8% (metals basis) 50GR 7439-88-5 011430.BU ALF-011430-BU Iridium wire, 0.5mm (0.02in) dia, 99.8% (metals basis) 25CM 105-55-5 A17143.0B ALF-A17143-0B N,N’-Diethylthiourea, 98% 1000GR 13292-46-1 J60836.14 ALF-J60836-14 Rifampin, Molecular Biology Reagent 25GR 97674-02-7 H31562.14 ALF-H31562-14 Tri-n-butyl(1-ethoxyvinyl)tin, 95% 25GR 143-67-9 J63598.MF ALF-J63598-MF Vinblastine sulfate, 98% 50MG 461-89-2 A14389.14 ALF-A14389-14 6-Azauracil, 98% 25GR 33069-62-4 J62734.ME ALF-J62734-ME Paclitaxel, 99.5+% 500MG 10108-64-2 036629.36 ALF-036629-36 Cadmium chloride, anhydrous, ACS, 99.0% min 500GR 1312-81-8 011264.A1 ALF-011264-A1 Lanthanum(III) oxide, REacton|r, 99.99% (REO) 1KG 2374-14-3 L16680.22 ALF-L16680-22 1,3,5-Trimethyl-1,3,5-tris(3,3,3-trifluoropropyl)cyclotrisiloxane, 97% 100GR 178312-62-4 B21749.06 ALF-B21749-06 Homomorpholine hydrochloride, 98% 5GR 10049-07-7 011815.06 ALF-011815-06 Rhodium(III) chloride, anhydrous, 99.9% (metals basis), Rh 48.7% min 5GR 7791-13-1 010692.18 ALF-010692-18 Cobalt(II) chloride hexahydrate, Puratronic|r, 99.998% (metals basis) 50GR 12037-01-3 011207.18 ALF-011207-18 Terbium(III,IV) oxide, REacton|r, 99.9% (REO) 50GR CAS MPN SAP CODE NAME PACK 33069-62-4 J62734.03 ALF-J62734-03 Paclitaxel, 99.5+% 1GR 16066-91-4 B20638.22 ALF-B20638-22 5-Iodoindole, 98% 100GR 1306-38-3 011328.A1 ALF-011328-A1 Cerium(IV) oxide, REacton|r, 99.9% (REO) 1KG 20667-12-3 011407.36 ALF-011407-36 Silver(I) oxide, 99+% (metals basis) 500GR 247564-72-3 H27858.14 ALF-H27858-14 2,4,5-Trifluorobenzeneboronic acid, 97% 25GR 1984-15-2 A14803.14 ALF-A14803-14 Methylenediphosphonic acid, 99+% 25GR 2799-21-5 L19499.06 ALF-L19499-06 (R)-(+)-3-Hydroxypyrrolidine, 99%, ee 99% 5GR 80657-57-4 044483.09 ALF-044483-09 Methyl (S)-(+)-3-hydroxy-2-methylpropionate, 99% 10GR 106-96-7 A16580.AK ALF-A16580-AK Propargyl bromide, 80% in toluene, stab. with MgO 250ML 21543-49-7 L19285.14 ALF-L19285-14 6-Chloropyridine-3-methanol, 98% 25GR 51484-06-1 H32009.14 ALF-H32009-14 6-Bromochromone-2-carboxylic acid, 97% 25GR 491-37-2 A11242.22 ALF-A11242-22 4-Chromanone, 98+% 100GR Glycolaldehyde diethyl acetal, stab. with ca 0.1% sodium carbonate, 621-63-6 L06282.18 ALF-L06282-18 50GR 98% 9012-36-6 J61123.36 ALF-J61123-36 Agarose, high melting temperature, medium resolution 500GR 011723.14 ALF-011723-14 Palladium, 5% on calcium carbonate powder, reduced 25GR 27328-86-5 A15564.14 ALF-A15564-14 3-(Trifluoromethyl)benzoylacetonitrile, 97% 25GR 7440-66-6 010760.30 ALF-010760-30 Zinc shot, 1-6mm (0.04-0.24in), Puratronic|r, 99.9999% (metals basis) 250GR 27298-97-1 L20080.14 ALF-L20080-14 (S)-(-)-1-(4-Bromophenyl)ethylamine, ChiPros, 99%, ee 98% 25GR 93777-26-5 A14219.30 ALF-A14219-30 5-Bromo-2-fluorobenzaldehyde, 98% 250GR 045467.A4 ALF-045467-A4 Iron-chrome based high temperature gas shift catalyst, HiFUEL|r W210 2.5KG 108-95-2 033213.A3 ALF-033213-A3 Phenol, ACS, 99+%, stab. 2KG 4521-31-7 L11536.14 ALF-L11536-14 2-Mercaptobenzyl alcohol, tech. 90% 25GR 2420-16-8 A17515.22 ALF-A17515-22 3-Chloro-4-hydroxybenzaldehyde, 98% 100GR 14221-02-4 010549.06 ALF-010549-06 Tetrakis(triphenylphosphine)platinum(0), Pt 15.2% min 5GR 62813-01-8 H27495.14 ALF-H27495-14 1-Cyclopropyl-4-piperidone, 98% 25GR 60022-62-0 H28790.14 ALF-H28790-14 L-Serine benzyl ester hydrochloride, 98% 25GR 1572-98-1 H31432.18 ALF-H31432-18 Ethyl 2-cyano-2-methylpropionate, 97% 50GR 107-19-7 A10295.0F ALF-A10295-0F Propargyl alcohol, 99% 2500ML 110-13-4 B25686.36 ALF-B25686-36 2,5-Hexanedione, 97% 500GR 157-06-2 A16137.06 ALF-A16137-06 D-Arginine, 98% 5GR 626-39-1 B23860.36 ALF-B23860-36 1,3,5-Tribromobenzene, 98% 500GR 68938-01-2 J65753.06 ALF-J65753-06 Deoxyribonucleic acid sodium salt, salmon testes 5GR 69-53-4 J60977.14 ALF-J60977-14 Ampicillin 25GR 13035-19-3 L20127.14 ALF-L20127-14 4-Aminopiperidine, 98% 25GR CAS MPN SAP CODE NAME PACK 6299-25-8 B21416.14 ALF-B21416-14 4,6-Dichloro-2-(methylthio)pyrimidine, 98% 25GR 56-45-1 A11179.36 ALF-A11179-36 L-Serine, 99% 500GR 872-35-5 L01346.06 ALF-L01346-06 2-Mercaptoimidazole, 98+% 5GR 1-Ethyl-3-methylimidazolium tetrafluoroborate, 98+% (dry wt.), may cont. 143314-16-3 L19763.18 ALF-L19763-18 50GR up to 3% water 51010-74-3 L19751.14 ALF-L19751-14 4-Morpholinylsulfur trifluoride, 95% 25GR 6487-48-5 A12289.0I ALF-A12289-0I Potassium oxalate hydrate, 99% 5000GR 402-67-5 B25553.22 ALF-B25553-22 1-Fluoro-3-nitrobenzene, 98+% 100GR 14348-41-5 B21338.30 ALF-B21338-30 3-Bromo-4-hydroxybenzoic acid, 98% 250GR 7440-00-8 040294.DM ALF-040294-DM Neodymium rod, 12.7mm (0.5in) dia, 99.5% (metals basis excluding Ta) 100MM 1314-36-9 040648.36 ALF-040648-36 Yttrium(III) oxide pellets, 99.9% (REO) 500GR 7440-50-8 000622.30 ALF-000622-30 Copper powder, -625 mesh, APS 2-3.50 micron, 99% (metals basis) 250GR 27246-81-7 B23510.22 ALF-B23510-22 3-Bromophenylhydrazine hydrochloride, 98% 100GR Hydrogen tetrabromoaurate(III) hydrate, Premion|r, 99.99% (metals basis), 040433.03 ALF-040433-03 1GR Au 32% min 7631-86-9 042723.A1 ALF-042723-A1 Silica gel 60, 0.075-0.2mm (70-200 mesh) 1KG 2345-61-1 A15527.14 ALF-A15527-14 trans-3-Chloroacrylic acid, 99% 25GR 4652-27-1 A11235.30 ALF-A11235-30 4-Methoxy-3-buten-2-one, tech. 90% 250GR 3034-38-6 A12458.14 ALF-A12458-14 4-Nitroimidazole, 97% 25GR 4394-85-8 B23315.0E ALF-B23315-0E 4-Formylmorpholine, 99% 2500GR 4792-15-8 A10133.30 ALF-A10133-30 Pentaethylene glycol, 98+% 250GR 100-86-7 L03679.36 ALF-L03679-36 2-Methyl-1-phenyl-2-propanol, 98+% 500GR 12060-58-1 010915.22 ALF-010915-22 Samarium(III) oxide, REacton|r, 99.998% (metals basis), REM 100ppm 100GR 42969-65-3 L18880.06 ALF-L18880-06 (R)-(+)-3-Butyn-2-ol, 99% 5GR 67-68-5 036480.M6 ALF-036480-M6 Dimethyl sulfoxide, ACS, 99.9% min 4x4L 352530-25-7 H25947.06 ALF-H25947-06 5-Formyl-4-methylthiophene-2-boronic acid, 97% 5GR 12030-24-9 044835.18 ALF-044835-18 Indium(III) sulfide, 99.98% (metals basis) 50GR 9004-74-4 041560.36 ALF-041560-36 Polyethylene glycol monomethylether, 350 500GR 34513-98-9 012175.14 ALF-012175-14 Ruthenium(III) nitrosylnitrate, Ru 31.3% min 25GR 1732-10-1 L17458.22 ALF-L17458-22 Dimethyl azelate, 97% 100GR 58-85-5 A14207.09 ALF-A14207-09 D-(+)-Biotin, 98+% 10GR 745784-10-5 L20341.06 ALF-L20341-06 2-Fluoroquinoline-3-boronic acid, 97% 5GR 83-33-0 A11056.36 ALF-A11056-36 1-Indanone, 99+% 500GR 3095-38-3 L02704.06 ALF-L02704-06 3,5-Dimethyl-4-nitrobenzoic acid, 97% 5GR 151-21-3 J67606.30 ALF-J67606-30 Sodium n-dodecyl sulfate, 99%, Molecular Biology Grade 250GR 10377-52-3 010743.22 ALF-010743-22 Lithium phosphate, Puratronic|r, 99.99% (metals basis) 100GR CAS MPN SAP CODE NAME PACK Gold slug, 6.35mm (0.25in) dia x 6.35mm (0.25in) length, Premion|r, 7440-57-5 014174.KG ALF-014174-KG 1PC 99.999% (metals basis) 19545-26-7 J63983.MF ALF-J63983-MF Wortmannin, Penicillium funiculosum, 99+% 50MG 13781-53-8 A12805.14 ALF-A12805-14 3-Thiopheneacetonitrile, 98% 25GR 541-59-3 A13135.30 ALF-A13135-30 Maleimide, 98+% 250GR 544-76-3 A10322.0F ALF-A10322-0F n-Hexadecane, 99% 2500ML Palladium, 10% on activated carbon powder, Type 87L, standard, re- 045924.14 ALF-045924-14 25GR duced, nominally 50% water wet 19545-26-7 J63983.MB ALF-J63983-MB Wortmannin, Penicillium funiculosum, 99+% 25MG 22353-34-0 H31833.06 ALF-H31833-06 3-Amino-5-chloropyridine, 95% 5GR 7440-21-3 036212.30 ALF-036212-30 Silicon powder, crystalline, -100+325 mesh, 99.999% (metals basis) 250GR 20634-12-2 088960.06 ALF-088960-06 Tetraammineplatinum(II) nitrate 5GR 675-62-7 L16669.22 ALF-L16669-22 (3,3,3-Trifluoropropyl)methyldichlorosilane, 97% 100GR 161265-03-8 H26241.14 ALF-H26241-14 4,5-Bis(diphenylphosphino)-9,9-dimethylxanthene, 97% 25GR 16561-29-8 J63916.MB ALF-J63916-MB Phorbol 12-myristate 13-acetate, 99+% 25MG 1314-36-9 011182.A1 ALF-011182-A1 Yttrium(III) oxide, REacton|r, 99.999% (REO) 1KG 10139-47-6 011661.30 ALF-011661-30 Zinc iodide, 98% 250GR 39450-01-6 J62051.MC ALF-J62051-MC Proteinase K, Tritirachium album limber 100MG 927-80-0 A14245.14 ALF-A14245-14 Ethoxyacetylene, ca 50% w/w in hexanes 25GR Dihydrogen hexachloroplatinate(IV) hexahydrate, low nitrate, Premion|r, 18497-13-7 042815.14 ALF-042815-14 25GR 99.95% (metals basis), Pt 37.5% min 693-02-7 A13156.30 ALF-A13156-30 1-Hexyne, 98+% 250GR 7440-48-4 042660.FI ALF-042660-FI Cobalt foil, 1.0mm (0.04in) thick, 99.95% (metals basis) 50x50MM
Load more

Recommended publications
  • Aldrich FT-IR Collection Edition I Library
    Aldrich FT-IR Collection Edition I Library Library Listing – 10,505 spectra This library is the original FT-IR spectral collection from Aldrich. It includes a wide variety of pure chemical compounds found in the Aldrich Handbook of Fine Chemicals. The Aldrich Collection of FT-IR Spectra Edition I library contains spectra of 10,505 pure compounds and is a subset of the Aldrich Collection of FT-IR Spectra Edition II library. All spectra were acquired by Sigma-Aldrich Co. and were processed by Thermo Fisher Scientific. Eight smaller Aldrich Material Specific Sub-Libraries are also available. Aldrich FT-IR Collection Edition I Index Compound Name Index Compound Name 3515 ((1R)-(ENDO,ANTI))-(+)-3- 928 (+)-LIMONENE OXIDE, 97%, BROMOCAMPHOR-8- SULFONIC MIXTURE OF CIS AND TRANS ACID, AMMONIUM SALT 209 (+)-LONGIFOLENE, 98+% 1708 ((1R)-ENDO)-(+)-3- 2283 (+)-MURAMIC ACID HYDRATE, BROMOCAMPHOR, 98% 98% 3516 ((1S)-(ENDO,ANTI))-(-)-3- 2966 (+)-N,N'- BROMOCAMPHOR-8- SULFONIC DIALLYLTARTARDIAMIDE, 99+% ACID, AMMONIUM SALT 2976 (+)-N-ACETYLMURAMIC ACID, 644 ((1S)-ENDO)-(-)-BORNEOL, 99% 97% 9587 (+)-11ALPHA-HYDROXY-17ALPHA- 965 (+)-NOE-LACTOL DIMER, 99+% METHYLTESTOSTERONE 5127 (+)-P-BROMOTETRAMISOLE 9590 (+)-11ALPHA- OXALATE, 99% HYDROXYPROGESTERONE, 95% 661 (+)-P-MENTH-1-EN-9-OL, 97%, 9588 (+)-17-METHYLTESTOSTERONE, MIXTURE OF ISOMERS 99% 730 (+)-PERSEITOL 8681 (+)-2'-DEOXYURIDINE, 99+% 7913 (+)-PILOCARPINE 7591 (+)-2,3-O-ISOPROPYLIDENE-2,3- HYDROCHLORIDE, 99% DIHYDROXY- 1,4- 5844 (+)-RUTIN HYDRATE, 95% BIS(DIPHENYLPHOSPHINO)BUT 9571 (+)-STIGMASTANOL
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2009/0156618 A1 Tollefson (43) Pub
    US 20090156618A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2009/0156618 A1 Tollefson (43) Pub. Date: Jun. 18, 2009 (54) 1-(1-(2-ETHOXYETHYL)-3-ETHYL-7- Related U.S. Application Data (4-METHYLPYRIDIN-2-YLAMINO) - 1H-PYRAZOLO 4.3-D PYRIMIDIN-5-YL) (60) Provisional application No. 60/735,320, filed on Nov. PPERDINE-4-CARBOXYLIC ACID AND 10, 2005. SALTS THEREOF Publication Classification (51) Int. Cl. (75) Inventor: Michael B. Tollefson, Dardenne A 6LX 3/59 (2006.01) Prairie, MO (US) C07D 487/04 (2006.01) A6IP 9/12 (2006.01) A6IP 25/00 (2006.01) Correspondence Address: A6IP 9/00 (2006.01) PFZER INC. PATENT DEPARTMENT, Bld 114 M/S 114, (52) U.S. Cl. ...................................... 514/262.1; 54.4/262 EASTERN PONT ROAD (57) ABSTRACT GROTON, CT 06340 (US) The present invention comprises 1-(1-(2-ethoxyethyl)-3- ethyl-7-(4-methylpyridin-2-ylamino)-1H-pyrazolo 4.3-d (73) Assignee: Pfizer Inc pyrimidin-5-yl)piperidine-4-carboxylic acid and its salts. The invention further comprises pharmaceutical composi tions, methods of treatment, and synthetic methods relating to (21) Appl. No.: 111558,306 1-(1-(2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2- ylamino)-1H-pyrazolo 4.3-dipyrimidin-5-yl)piperidine-4- (22) Filed: Nov. 9, 2006 carboxylic acid and its salts. Patent Application Publication Jun. 18, 2009 Sheet 2 of 2 US 2009/0156618 A1 "SOIHZ US 2009/0156618 A1 Jun. 18, 2009 1-(1-(2-ETHOXYETHYL)-3-ETHYL-7- 1H-pyrazolo 4,3-dipyrimidin-5-yl)piperidine-4-carboxylic (4-METHYLPYRIDIN-2-YLAMINO) - acid and its pharmaceutically acceptable salts.
    [Show full text]
  • Campro Catalog Stable Isotope
    Introduction & Welcome Dear Valued Customer, We are pleased to present to you our Stable Isotopes Catalog which contains more than three thousand (3000) high quality labeled compounds. You will find new additions that are beneficial for your research. Campro Scientific is proud to work together with Isotec, Inc. for the distribution and marketing of their stable isotopes. We have been working with Isotec for more than twenty years and know that their products meet the highest standard. Campro Scientific was founded in 1981 and we provide services to some of the most prestigious universities, research institutes and laboratories throughout Europe. We are a research-oriented company specialized in supporting the requirements of the scientific community. We are the exclusive distributor of some of the world’s leading producers of research chemicals, radioisotopes, stable isotopes and environmental standards. We understand the requirements of our customers, and work every day to fulfill them. In working with us you are guaranteed to receive: - Excellent customer service - High quality products - Dependable service - Efficient distribution The highly educated staff at Campro’s headquarters and sales office is ready to assist you with your questions and product requirements. Feel free to call us at any time. Sincerely, Dr. Ahmad Rajabi General Manager 180/280 = unlabeled 185/285 = 15N labeled 181/281 = double labeled (13C+15N, 13C+D, 15N+18O etc.) 186/286 = 12C labeled 182/282 = d labeled 187/287 = 17O labeled 183/283 = 13C labeleld 188/288 = 18O labeled 184/284 = 16O labeled, 14N labeled 189/289 = Noble Gases Table of Contents Ordering Information.................................................................................................. page 4 - 5 Packaging Information ..............................................................................................
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2007/0254920 A1 Delong Et Al
    US 20070254920A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2007/0254920 A1 deLong et al. (43) Pub. Date: Nov. 1, 2007 (54) PRODRUG DERIVATIVES OF ACIDS USING (52) U.S. Cl. ......................... 514/319; 514/323: 514/573; ALCOHOLS WITH HOMOTOPIC HYDROXY 514/415: 514/443; 514/469; GROUPS AND METHODS FOR THEIR 546/196; 546/201: 546/206; PREPARATION AND USE 548/495; 549/49; 549/462 (75) Inventors: Mitchell A. deLong, Raleigh, NC (US); (57) ABSTRACT Jill M. McFadden, Chapel Hill, NC This invention relates to novel homotopic prodrugs and (US); Susan M. Royalty, Cary, NC medicaments and methods for their preparation, testing and (US); Eric J. Toone, Durham, NC use. In one embodiment, the homotopic prodrug has the (US); Jeffrey D. Yingling, Apex, NC general formula (US) Correspondence Address: O MICHAEL BEST & FRIEDRCH LLP 100 E WISCONSNAVENUE Rb, Suite 3300 --- MILWAUKEE, WI 53202 (US) wherein (73) Assignee: Aerie Pharmaceuticals, Inc., Research Triangle Park, NC (21) Appl. No.: 11/412,207 (22) Filed: Apr. 26, 2006 -- Publication Classification is a biologically-active moiety comprising a carboxylic acid functional group, and R is a homotopically-symmetrical (51) Int. Cl. alcohol bonded to the biologically-active moiety through the A6 IK 3/558 (2006.01) carboxylic acid functional group to form an ester linkage, as CO7D 409/02 (2006.01) well as optical isomers, enantiomers, pharmaceutically CO7D 405/02 (2006.01) acceptable salts, biohydrolyzable amides, esters, and imides CO7D 403/02 (2006.01) thereof and combinations thereof. US 2007/0254920 A1 Nov. 1, 2007 PRODRUG DERVATIVES OF ACDS USING WO 99/12896, and WO 99/12898.) However, such modifi ALCOHOLS WITH HOMOTOPIC HYDROXY cations have either resulted in only modest increases in GROUPS AND METHODS FOR THEIR half-life or resulted in compounds with diminished potency.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 7,304,086 B2 Schilling Et Al
    USOO7304086B2 (12) United States Patent (10) Patent No.: US 7,304,086 B2 Schilling et al. (45) Date of Patent: *Dec. 4, 2007 (54) INHIBITORS OF GLUTAMINYL CYCLASE WO WOOO,53596 9, 2000 WO WO O1/34594 A1 5, 2001 (75) Inventors: Stephan Schilling, Halle/Saale (DE); WO WO O2, 13821 2, 2002 WO WO O2, 16318 A1 2, 2002 Mirko Buchholz, Halle/Saale (DE): WO WO O2O16318 A1 * 2/2002 Andre Johannes Niestroj, Sennewitz WO WO O2/O66459 A1 8, 2002 (DE); Ulrich Heiser, Halle/Saale (DE): WO WO O2/O92103 A1 11 2002 Hans-Ulrich Demuth, Halle/Saale (DE) WO WO O2O94813 A1 * 11/2002 WO WO 03/04.0174 A2 5, 2003 (73) Assignee: Probiodrug AG, Halle/Saale (DE) WO WO O3,O70732 8, 2003 WO WO O3068738 8, 2003 (*) Notice: Subject to any disclaimer, the term of this WO WO O30954.21 A1 * 11/2003 patent is extended or adjusted under 35 WO WO 2004O26815 A2 * 4, 2004 U.S.C. 154(b) by 20 days. WO WO 2004/089366 10, 2004 WO WO 2004/098591 A2 11 2004 This patent is Subject to a terminal dis WO WO 2004/098.625 A2 11 2004 claimer. OTHER PUBLICATIONS (21) Appl. No.: 11/051,760 Haley et al. Giorn. Ital. Chemioterap. (1962) 6-9 (No. 3), 213-24. Abstract from CAS attached. (22) Filed: Feb. 4, 2005 Hough et al. Pharmacology, Biochemistry and Behavior 1999, 65(1), 61-66. * Abstract from CAS attached.* (65) Prior Publication Data Morissette et al. Advanced Drug Delivery Reviews 2004, 56. US 2005/0215573 A1 Sep.
    [Show full text]
  • Synthesis of Polycyclic Natural Products Jianmin Shi Iowa State University
    Iowa State University Capstones, Theses and Retrospective Theses and Dissertations Dissertations 1990 Synthesis of polycyclic natural products Jianmin Shi Iowa State University Follow this and additional works at: https://lib.dr.iastate.edu/rtd Part of the Organic Chemistry Commons Recommended Citation Shi, Jianmin, "Synthesis of polycyclic natural products " (1990). Retrospective Theses and Dissertations. 9891. https://lib.dr.iastate.edu/rtd/9891 This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Retrospective Theses and Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. JLÎMI MICROFILMED 1991 INFORMATION TO USERS The most advanced technology has been used to photograph and reproduce this manuscript from the microfihn master. UMI films the text directly from the original or copy submitted. Thus, some thesis and dissertation copies are in typewriter face, while others may be from any type of computer printer. The quality of this reproduction is dependent upon the quality of the copy submitted. Broken or indistinct print, colored or poor quality illustrations and photographs, print bleedthrough, substandard margins, and improper alignment can adversely affect reproduction. In the unlikely event that the author did not send UMI a complete manuscript and there are missing pages, these will be noted. Also, if unauthorized copyright material had to be removed, a note will indicate the deletion. Oversize materials (e.g., maps, drawings, charts) are reproduced by sectioning the original, beginning at the upper left-hand corner and continuing from left to right in equal sections with small overlaps.
    [Show full text]
  • Aldrich Organometallic, Inorganic, Silanes, Boranes, and Deuterated Compounds
    Aldrich Organometallic, Inorganic, Silanes, Boranes, and Deuterated Compounds Library Listing – 1,523 spectra Subset of Aldrich FT-IR Library related to organometallic, inorganic, boron and deueterium compounds. The Aldrich Material-Specific FT-IR Library collection represents a wide variety of the Aldrich Handbook of Fine Chemicals' most common chemicals divided by similar functional groups. These spectra were assembled from the Aldrich Collections of FT-IR Spectra Editions I or II, and the data has been carefully examined and processed by Thermo Fisher Scientific. Aldrich Organometallic, Inorganic, Silanes, Boranes, and Deuterated Compounds Index Compound Name Index Compound Name 1066 ((R)-(+)-2,2'- 1193 (1,2- BIS(DIPHENYLPHOSPHINO)-1,1'- BIS(DIPHENYLPHOSPHINO)ETHAN BINAPH)(1,5-CYCLOOCTADIENE) E)TUNGSTEN TETRACARBONYL, 1068 ((R)-(+)-2,2'- 97% BIS(DIPHENYLPHOSPHINO)-1,1'- 1062 (1,3- BINAPHTHYL)PALLADIUM(II) CH BIS(DIPHENYLPHOSPHINO)PROPA 1067 ((S)-(-)-2,2'- NE)DICHLORONICKEL(II) BIS(DIPHENYLPHOSPHINO)-1,1'- 598 (1,3-DIOXAN-2- BINAPH)(1,5-CYCLOOCTADIENE) YLETHYNYL)TRIMETHYLSILANE, 1140 (+)-(S)-1-((R)-2- 96% (DIPHENYLPHOSPHINO)FERROCE 1063 (1,4- NYL)ETHYL METHYL ETHER, 98 BIS(DIPHENYLPHOSPHINO)BUTAN 1146 (+)-(S)-N,N-DIMETHYL-1-((R)-1',2- E)(1,5- BIS(DI- CYCLOOCTADIENE)RHODIUM(I) PHENYLPHOSPHINO)FERROCENY TET L)E 951 (1,5-CYCLOOCTADIENE)(2,4- 1142 (+)-(S)-N,N-DIMETHYL-1-((R)-2- PENTANEDIONATO)RHODIUM(I), (DIPHENYLPHOSPHINO)FERROCE 99% NYL)ETHYLAMIN 1033 (1,5- 407 (+)-3',5'-O-(1,1,3,3- CYCLOOCTADIENE)BIS(METHYLD TETRAISOPROPYL-1,3- IPHENYLPHOSPHINE)IRIDIUM(I)
    [Show full text]
  • Perfluoroalkyl-Iodo Norbornane Compounds and Their Use As
    Europâisches Patentamt (g) ÛJ)) European Patent Office (0) Publication number: O 002 74 1 Office européen des brevets Bl © EUROPEAN PATENT SPECIFICATION @ Date of publication of patent spécification: 18.11.81 @© Int.lnt.CI.3: Cl.3: C 07 C 61/12, C07C 103/19, number: 78101696.9 @ Application CC07C 07 C 103/737,103/737 @ Date offiling: 15.12.78 C 07 D 209/76, C07B 29/04, C07C 69/74, C 07 D 307/77, B 01 F 17/00 (54) Perfluoroaikyl-iodo norbornane compounds and their use as surfactants. (§) Priority: 27.12.77 US 865060 @ Proprietor: CIBA-GEIGY AG Patentabteilung Postfach CH-4002 Basel (CH) (43) Date of publication of application: 11.07.79 Bulletin 79/14 (72) Inventor: Brace, Neal O. 1 022 East North Path (45) Publication of the grant of the European patent: Wheaton Illinois 60187 (US) 18.11.81 Bulletin 81/46 (84) Designated Contracting States: CH DE FR GB (56) References cited: NL - A - 68 08078 Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1 ) European patent convention). Courier Press, Leamington Spa, England. The compounds of this invention are perfluoroalkyliodo norbornane derivatives of the formula wherein Y is independently oxygen or the group >NR, R is independently hydrogen or alkyl of 1 to 24 carbon atoms or each group - YR is independently halogen with the proviso that if two halogen atoms are present these are identical and Rf is a straight or branched chain perfluoroalkyl of 1 to 18 carbon atoms or said perfluoroalkyl substituted by a perfluoroalkoxy group of 2 to 6 carbon atoms.
    [Show full text]
  • Revised Group Additivity Values for Enthalpies of Formation (At 298 K) of Carbon– Hydrogen and Carbon–Hydrogen–Oxygen Compounds
    Revised Group Additivity Values for Enthalpies of Formation (at 298 K) of Carbon– Hydrogen and Carbon–Hydrogen–Oxygen Compounds Cite as: Journal of Physical and Chemical Reference Data 25, 1411 (1996); https://doi.org/10.1063/1.555988 Submitted: 17 January 1996 . Published Online: 15 October 2009 N. Cohen ARTICLES YOU MAY BE INTERESTED IN Additivity Rules for the Estimation of Molecular Properties. Thermodynamic Properties The Journal of Chemical Physics 29, 546 (1958); https://doi.org/10.1063/1.1744539 Critical Evaluation of Thermochemical Properties of C1–C4 Species: Updated Group- Contributions to Estimate Thermochemical Properties Journal of Physical and Chemical Reference Data 44, 013101 (2015); https:// doi.org/10.1063/1.4902535 Estimation of the Thermodynamic Properties of Hydrocarbons at 298.15 K Journal of Physical and Chemical Reference Data 17, 1637 (1988); https:// doi.org/10.1063/1.555814 Journal of Physical and Chemical Reference Data 25, 1411 (1996); https://doi.org/10.1063/1.555988 25, 1411 © 1996 American Institute of Physics for the National Institute of Standards and Technology. Revised Group Additivity Values for Enthalpies of Formation (at 298 K) of Carbon-Hydrogen and Carbon-Hydrogen-Oxygen Compounds N. Cohen Thermochemical Kinetics Research, 6507 SE 31st Avenue, Portland, Oregon 97202-8627 Received January 17, 1996; revised manuscript received September 4, 1996 A program has been undertaken for the evaluation and revision of group additivity values (GAVs) necessary for predicting, by means of Benson's group additivity method, thermochemical properties of organic molecules. This review reports on the portion of that program dealing with GAVs for enthalpies of formation at 298.15 K (hereinafter abbreviated as 298 K) for carbon-hydrogen and carbon-hydrogen-oxygen compounds.
    [Show full text]
  • Chlorine Dioxide Gas Treatment of Cantaloupe and Residue Analysis Simran Kaur Purdue University
    Purdue University Purdue e-Pubs Open Access Theses Theses and Dissertations 2013 Chlorine Dioxide Gas Treatment of Cantaloupe and Residue Analysis Simran Kaur Purdue University Follow this and additional works at: https://docs.lib.purdue.edu/open_access_theses Part of the Food Science Commons Recommended Citation Kaur, Simran, "Chlorine Dioxide Gas Treatment of Cantaloupe and Residue Analysis" (2013). Open Access Theses. 47. https://docs.lib.purdue.edu/open_access_theses/47 This document has been made available through Purdue e-Pubs, a service of the Purdue University Libraries. Please contact [email protected] for additional information. CHLORINE DIOXIDE GAS TREATMENT OF CANTALOUPE AND RESIDUE ANALYSIS A Thesis Submitted to the Faculty of Purdue University by Simran Kaur In Partial Fulfillment of the Requirements for the Degree of Master of Science December 2013 Purdue University West Lafayette, Indiana ii Two cantaloupes were in love. One said to the other, “Let’s run away together!” The other one said, “No. We cantelope.” iii ACKNOWLEDGEMENTS I would like to thank Dr. Mark Morgan for giving me the opportunity to work on this project. I truly appreciate his support, encouragement and guidance and have thoroughly enjoyed every moment. I would also like to thank my committee members, Dr. Mario Ferruzzi and Dr. Peter Hirst for their suggestions, feedback and comments. Thank you to Ben Paxson for his help with equipment and also to Dr. Applegate for the lab space to do my project. I am also thankful for the help and support from all my friends, old and new, close and far, for their support and companionship throughout my graduate studies, especially my dear friend Nadra Guizani.
    [Show full text]
  • 3-D Nano and Micro Structures
    TM Vol. 3, No. 1 3-D Nano and Micro Structures Inks for Direct-Write 3-D Assembly Colloidal Crystal Templating Small Structures Inspiring Electrospinning Big Technologies Quantum Dots: Nanoscale Synthesis and Micron-Scale Applications 2 Introduction TM Welcome to the first 2008 issue of Material Matters™, focusing on 3-dimensional (3D) micro- and nanostructures. New techniques to create materials ordered at micro- Vol. 3 No. 1 and nanoscale drive scientific and technological advances in many areas of science and engineering. For example, 3D-patterned metal oxides could enable construction of micro-fuel cells and high-capacity batteries smaller and more energy efficient compared to presently available devices. Ordered porous materials with exceedingly large surface areas are good candidates for highly efficient catalysts and sensors. Aldrich Chemical Co., Inc. New methods for periodic patterning of semiconductor materials are fundamental Sigma-Aldrich Corporation to next-generation electronics, while individual nanoscale semiconductor structures, 6000 N. Teutonia Ave. known as quantum dots (QDs), have remarkable optical properties for optoelectronics Milwaukee, WI 53209, USA and imaging applications. And biomedical engineers are using tailored nanofibers and patterned polymeric structures to develop tissue-engineering scaffolds, drug-delivery devices and microfluidic networks. To Place Orders The broad diversity of potentially relevant material types and architectures underscores Telephone 800-325-3010 (USA) the need for new approaches to make 3D micro- and nanostructures. In this issue, FAX 800-325-5052 (USA) Introduction Professor Jennifer Lewis (University of Illinois at Urbana-Champaign) describes direct- write printing of 3D periodic arrays. This work depends on formulation of suitable Customer & Technical Services inks, many of which can be prepared using particles and polyelectrolytes available Customer Inquiries 800-325-3010 from Sigma-Aldrich®.
    [Show full text]
  • NXP Semiconductors NXP List of Hazardous Substances in Products
    NXP Semiconductors NX3-00119 NXP List of Hazardous Substances Sustainability 01-October-2012 in Products and Packaging Sustainability Page 1 of 7 Supersedes: NX3-00119 01-October-2010 Table of contents 1 Objectives ............................................................................................................................. 2 2 Scope ................................................................................................................................... 2 3 Responsibilities, Records & Risks......................................................................................... 2 3.1 Roles and Responsibilities .................................................................................................... 2 3.2 Records ................................................................................................................................ 2 3.3 Risks .................................................................................................................................... 3 4 References ........................................................................................................................... 3 5 Definitions/Abbreviations ...................................................................................................... 3 5.1 Definitions ............................................................................................................................. 3 5.2 Abbreviations .......................................................................................................................
    [Show full text]